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We have recently shown that following peroral low-dose Toxoplasma gondii infection
susceptible mice develop subacute ileitis within 10 days. Data regarding long-term
intestinal and extra-intestinal sequelae of infection are scarce, however. We therefore
challenged conventional C57BL/6 mice with one cyst of T. gondii ME49 strain by
gavage and performed a comprehensive immunopathological survey 10, 36, and 57
days later. As early as 10 days post-infection, mice were suffering from subacute
ileitis as indicated by mild-to-moderate histopathological changes of the ileal mucosa.
Furthermore, numbers of apoptotic and proliferating/regenerating epithelial cells as well
as of T and B lymphocytes in the mucosa and lamina propria of the ileum were highest
at day 10 post-infection, but declined thereafter, and were accompanied by enhanced
pro-inflammatory mediator secretion in ileum, colon and mesenteric lymph nodes that
was most pronounced during the early phase of infection. In addition, subacute ileitis
was accompanied by distinct shifts in the commensal gut microbiota composition in the
small intestines. Remarkably, immunopathological sequelae of T. gondii infection were
not restricted to the intestines, but could also be observed in extra-intestinal tissues
including the liver, kidneys, lungs, heart and strikingly, in systemic compartments that
were most prominent at day 10 post-infection. We conclude that the here provided
long-term kinetic survey of immunopathological sequalae following peroral low-dose
T. gondii infection provides valuable corner stones for a better understanding of the
complex interactions within the triangle relationship of (parasitic) pathogens, the host
immunity and the commensal gut microbiota during intestinal inflammation. The low-dose
T. gondii infection model may be applied as valuable gut inflammation model in future
pre-clinical studies in order to test potential treatment options for intestinal inflammatory
conditions in humans.
Keywords: subacute and chronic ileitis, low-dose Toxoplasma gondii infection, Th1-type immunopathology, gut
microbiota changes, host-pathogen-interactions
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INTRODUCTION
Within 1 week following peroral high-dose infection with more
than 50 cysts of the intracellular protozoan parasite Toxoplasma
gondii strain ME49 susceptible mice irrespective whether
harboring a murine or human gut microbiota develop acute
necrotizing inflammation of the terminal ileum with lethal
outcome (Heimesaat et al., 2006; Munoz et al., 2011; von
Klitzing et al., 2017a,b). This CD4+ T lymphocyte dependent
inflammatory condition is characterized by massive secretion
of pro-inflammatory mediators such as TNF, IFN-γ, and nitric
oxide, whereas IL-10 expression is upregulated as counter-
regulatory measure (Liesenfeld et al., 1996, 1999; Jankovic
et al., 2010; Munoz et al., 2011). Given the terminal ileum as
predilection site, the underlying Th1-type immunopathology,
and the pronounced changes in the commensal gut microbiota
composition (i.e., dysbiosis) characterized by an overgrowth of
the inflamed ileal lumen with commensal Escherichia coli and
Bacteroides / Prevotella species, the high-dose T. gondii infection
model mimics key features of human inflammatory bowel
diseases such as Crohn’s disease (Liesenfeld, 2002; Heimesaat
et al., 2006; Munoz et al., 2009, 2011, 2015). However, data
regarding long-term intestinal and extra-intestinal sequelae of
peroral murine T. gondii post-infection resulting in intestinal
inflammation are lacking due to the fatal immunopathological
course within 1 week post infection (p.i).
We have previously established a subacute and non-lethal
ileitis model following peroral low-dose (i.e., one cyst) T.
gondii ME49 strain infection (Dunay et al., 2008; Escher et al.,
2018; Heimesaat et al., 2018a). In order to further dissect the
interplay between parasite, host immunity and gut microbiota
(the latter mimicking human conditions) during infection-
induced inflammation we had generated mice harboring a
complex human gut microbiota prior ileitis induction (Bereswill
et al., 2011; von Klitzing et al., 2017a,b,c,d; Escher et al.,
2018; Heimesaat et al., 2018a,b). Within 9 days p.i. mice
were suffering from T cell dependent subacute ileitis that was
characterized by rather mild symptoms and mild-to-moderate
ileal histopathological changes without necrosis (Escher et al.,
2018; Heimesaat et al., 2018a). We did, however, not follow-up
mice suffering from subacute ileitis beyond day 9 p.i.
This prompted us in the present study to perform a
comprehensive long-term immunopathological survey of
conventional C57BL/6j mice until day 57 following ileitis
induction. We here demonstrate that immunopathological
sequelae of ileitis induction (i) were most severe during the
early phase of peroral low-dose T. gondii infection (i.e., around
day 10 p.i.), (ii) affected not only the terminal ileum but also
the colon, (iii) were accompanied by distinct shifts in the
commensal microbiota composition within the ileal lumen,
and (iv) were not restricted to the intestinal tract but could
Abbreviations: CBA, cytometric bead array; H&E, hematoxylin and eosin; IBD,
inflammatory bowel disease; IFN, interferon; IL, interleukin; MLN, mesenteric
lymph nodes; NOD, nucleotide-oligomerization-domain; PBS, phosphate-buffered
saline; p.i., post-infection; SPF, specific pathogen free; TLR, toll-like receptor; TNF,
tumor necrosis factor; WT, wildtype.




Mouse experiments were performed in accordance with the
European Guidelines for animal welfare (2010/63/EU). The
protocols for these experiments were approved by “Landesamt
für Gesundheit und Soziales,” LaGeSo, Berlin (registration
numbers G244/98). Clinical conditions of mice were assessed at
least once daily.
Mice and T. gondii Infection
C57BL/6j mice were reared and housed under specific pathogen
free (SPF) conditions in the Forschungseinrichtungen für
Experimentelle Medicine (Charité—University Medicine Berlin).
Conventionally colonized female mice 12 weeks of age were
included into the experiments. On day (d) 0, mice were perorally
subjected to low-dose T. gondii infection (i.e., one cyst of
strain ME49 in a volume of 0.3mL by gavage) as described
recently (Heimesaat et al., 2006, 2018a). T. gondii DNA was
quantitated in homogenized ileal tissue (∼1 cm2) as stated
elsewhere (Munoz et al., 2009).
Sampling Procedures
At defined time points, namely d10, d36, or d57 p.i., mice were
sacrificed by isofluran inhalation (Abbott, Germany). Naive mice
served as uninfected controls. Upon necropsy, cardiac blood,
luminal ileal samples as well as ex vivo biopsies from mesenteric
lymph nodes (MLN), spleen, liver, kidneys, lungs, heart, colon
and ileum were obtained under sterile conditions.
Histopathology
After removal ileal ex vivo biopsies were immediately fixed
in 5% formalin and embedded in paraffin. After hematoxylin
and eosin (H&E) staining, histopathological changes were
quantitatively assessed in 5µm thin sections applying a
standardized scoring system ranging from 0 to 6 as stated
elsewhere (Heimesaat et al., 2006).
IMMUNOHISTOCHEMISTRY
For in situ immunohistochemical analyses ex vivo biopsies
were obtained from the ileum, colon, liver, kidneys, lungs and
the heart, immediately fixed in 5% formalin and embedded
in paraffin. In order to quantitatively determine apoptotic
and proliferating epithelial cells, macrophages and monocytes,
T lymphocytes and B lymphocytes cells, paraffin sections
(5µm) were stained with primary antibodies directed against
cleaved caspase 3 (Asp175, Cell Signaling, Beverly, MA,
USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100), F4/80
(# 14-4801, clone BM8, eBioscience, San Diego, CA, USA,
1:50), CD3 (#N1580, Dako, 1:10), and B220 (No. 14-0452-
81, eBioscience; 1:200), respectively, as described earlier
(Heimesaat et al., 2018b). Positively stained cells were then
determined applying light microscopy (magnification 100
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x and 400 x), and for each mouse the average number
of respective positively stained cells was assessed within
at least six high power fields (HPF, 0.287 mm2, 400 x
magnification) by a blinded independent investigator. In
order to provide a broader overview of the T. gondii induced
immunopathological sequelae, representative photomicrographs
of the immunohistochemically stained paraffin sections are
provided with lower magnification (100 x) in the Online
Supplemental Materials.
Pro- and Anti-inflammatory Mediator
Detection
Intestinal ex vivo biopsies were cut longitudinally, washed
in phosphate buffered saline (PBS; Gibco, Life Technologies,
UK), and strips of ∼1 cm2 tissue as well as ex vivo biopsies
derived from MLN (3 lymph nodes), liver (∼1 cm3), one
kidney (cut longitudinally), one lung, and spleen (one
third) were transferred to 24-flat-bottom well-culture
plates (Nunc, Germany) containing 500 µL serum-
free RPMI 1640 medium (Gibco, life technologies, UK)
supplemented with penicillin (100 U/mL) and streptomycin
(100µg/mL; PAA Laboratories, Germany). After 18 h at
37◦C, respective culture supernatants as well as serum
samples were tested for TNF, IFN-γ, MCP-1, IL-6, IL-
12p70, and IL-10 by the Mouse Inflammation Cytometric
Bead Assay (CBA; BD Biosciences, Germany) on a BD
FACSCanto II flow cytometer (BD Biosciences). Nitric
oxide was measured by the Griess reaction as stated
elsewhere (Heimesaat et al., 2006).
Gut Microbiota Analyses
DNA was extracted from ileal luminal samples as reported
recently (Heimesaat et al., 2006; Bereswill et al., 2014). In
brief, DNA was quantitated applying the Quant-iT PicoGreen
reagent (Invitrogen, UK) and adjusted to 1 ng per µL. The
total eubacterial load as well as the main bacterial groups
within the murine gut microbiota such as enterobacteria,
enterococci, lactobacilli, bifidobacteria, Bacteroides / Prevotella
species, Clostridium coccoides group, and Clostridium leptum
group were determined by quantitative real-time polymerase
chain reaction (qRT-PCR) with species-, genera- or group-
specific 16S rRNA gene primers (TibMolBiol, Germany) as stated
elsewhere (Heimesaat et al., 2010; Bereswill et al., 2011; Rausch
et al., 2013) (expressed as numbers of 16S rRNA gene copies per
ng DNA).
Statistical Analysis
Medians and levels of significance were determined by one-
way ANOVA or Kruskal-Wallis test followed by Tukey post-
correction for multiple comparisons (GraphPad Prism v7,
USA) as indicated. Two-sided probability (p) values ≤ 0.05
were considered significant. Experiments were reproduced
three times.
RESULTS
Intestinal Inflammatory Changes Upon
Peroral Low-Dose T. gondii Infection
In order to induce subacute ileitis, conventionally colonized mice
were perorally subjected to low-dose (i.e., one cyst of) T. gondii
challenge by gavage and to a comprehensive immunopathological
survey for almost 2 months p.i. Within 10 days upon infection
mild-to-moderate histopathological changes of the ileal mucosa
could be observed ranging from edematous mucosal blubbing,
leukocytic infiltrates of the ileal mucosa and lamina propria,
cell-free exudates into the small intestinal lumen, and cellular
shedding (p < 0.001 vs. naive; Figure 1A and Figure S1A).
As compared to day 10 p.i., median histopathological scores
quantitatively assessing ileal mucosal damage tended to be lower
at later time points, but did not reach statistical significance due
to high standard deviations (n.s.; Figure 1A and Figure S1A).
We additionally quantitatively surveyed intestinal inflammatory
responses applying in situ immunohistochemistry of intestinal
paraffin sections. In T. gondii infected mice, multifold increased
apoptotic ileal epithelial cell numbers could be determined at
days 10 and 57 (p < 0.001 and p < 0.01, respectively vs. naive)
with highest counts in ex vivo biopsies taken at day 10 p.i. (p <
0.001 vs. day 36 and day 57 p.i.; Figure 1B and Figure S1B). In
parallel, Ki67+ ileal epithelial cells indicative for cell proliferation
and regeneration counteracting T. gondii induced cell damage
increased to a maximum at day 10 p.i. (p < 0.001), declined
thereafter, but were still higher as compared to those in naive
control mice (p < 0.001; Figure 1C and Figure S1C).
Given that T. gondii induced ileitis is highly T cell dependent
(Munoz et al., 2011), we quantitated CD3+ T lymphocytes in the
ileal mucosa and lamina propria. In fact, T cell numbers almost
doubled with 10 days p.i., but declined back to naive counts
thereafter (p < 0.001; Figure 1D and Figure S1D). In addition,
T. gondii infected mice also displayed elevated B cell numbers in
their ileal mucosa and lamina propria at day 10 p.i. (p < 0.01;
Figure 1E and Figure S1E), but not at later time points.
We have recently observed that T. gondii induced
immunopathological responses within the intestinal tract
do not exclusively affect the terminal ileum, but also the large
intestines (Escher et al., 2018; Heimesaat et al., 2018a) and
therefore expanded our inflammatory survey to the colon.
Histopathological mucosal changes within in colonic mucosa
were rather minor, however (Figure S2A), and did not reach
statistical significance due to high standard deviations within
respective groups (n.s.; not shown). When quantitating apoptotic
cells by in situ immunohistochemistry, multifold increased
numbers of apoptotic colonic epithelial cells could be assessed
only at day 10 p.i. (p < 0.001; Figure 2A and Figure S2B), which
also held true for T lymphocytes (p < 0.001; Figure 2C and
Figure S2D) and B lymphocytes in the large intestinal mucosa
and lamina propria (p < 0.001; Figure 2D and Figure S2E). Like
in the ileum, elevated Ki67+ cells numbers could be observed
in the colonic epithelia upon T. gondii infection (p < 0.001;
Figure 2B and Figure S2C),
Hence, apoptotic, proliferating and T cell as well as B cell
responses within both, the small as well as the large intestines
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FIGURE 1 | Microscopic inflammatory sequelae in the ileum over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A)
Histopathological changes were quantified in H&E stained paraffin sections from ileal ex vivo biopsies assessing a standardized histopathological scoring system. Out
of six representative high power fields (HPF, 400x magnification) per animal the average numbers of (B) apoptotic (casapse3+, Casp3+) and (C) proliferating (Ki67+)
ileal epithelial cells as well as of (D) T lymphocytes (CD3+) and (E) B lymphocytes within the ileal mucosa and lamina propria were assessed in immunohistochemically
stained small intestinal paraffin sections. Medians (black bars), levels of significance (p-values) as determined by one-way ANOVA test followed by Tukey
post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 April 2019 | Volume 9 | Article 98
Heimesaat et al. Immunopathology in Murine Low-Dose Toxoplasma gondii-Infection
FIGURE 2 | Microscopic inflammatory sequelae in the colon over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six
representative high power fields (HPF, 400x magnification) per animal the average numbers of (A) apoptotic (casapse3+, Casp3+) and (B) proliferating (Ki67+) colonic
epithelial cells as well as of (C) T lymphocytes (CD3+) and (D) B lymphocytes within the colonic mucosa and lamina propria were assessed in immunohistochemically
stained large intestinal paraffin sections. Medians (black bars), levels of significance (p-values) as determined by one-way ANOVA test followed by Tukey
post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.
were most pronounced 10 days following peroral low-dose
T. gondii infection.
Intestinal Inflammatory Mediator Secretion
Upon Peroral Low-Dose T. gondii Infection
We next assessed pro-inflammatory mediator secretion in ex
vivo biopsies derived from distinct intestinal compartments
(Figure 3). At day 10 p.i., increased ileal nitric oxide and IFN-γ
concentrations could be measured (p < 0.001; Figures 3A,C),
that declined to naive levels thereafter. In the colon, however,
increased TNF concentrations could be observed at either time
point p.i. (p< 0.05-0.001; Figure 3E) withmaximum levels at day
10 p.i. (p < 0.001; Figure 3E). Alike the ileum, increased IFN-γ
concentrations were measured in large intestinal ex vivo biopsies
exclusively at day 10 p.i. (p < 0.001; Figure 3F), whereas elevated
colonic TNF levels could be measured at days 10 and 57 p.i. (p <
0.001 and p < 0.05, respectively; Figure 3E).
We further surveyed pro-inflammatory mediator secretion in
MLN draining the inflamed intestines. As early as day 10 p.i.,
TNF and IFN-γ concentrations had increased in the MLN (p <
0.001; Figures 3H,I), but declined to naive levels later-on, which
also held true for nitric oxide (p < 0.05–0.005; Figure 3G).
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FIGURE 3 | Intestinal pro-inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles).
Pro-inflammatory mediators such as (A,D,G) nitric oxide, (B,E,H) TNF and (C,F,I) IFN-γ were measured in ex vivo biopsies taken from distinct intestinal compartments
including the (A–C) ileum, (D–F) colon and (G–I) mesenteric lymph nodes (MLN) at respective time points. Medians (black bars), levels of significance (p-values) as
determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data
were pooled from four independent experiments.
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Hence, peroral low dose T. gondii infection was accompanied
by pronounced pro-inflammatory mediator secretion in the
entire intestinal tract, particularly during the early phase (i.e., the
first 10 days p.i.).
Intestinal Microbiota Changes Upon
Peroral Low-Dose T. gondii Infection
Given that inflammatory processes in the intestinal tract
are associated with pronounced shifts in the gut microbiota
composition (Heimesaat et al., 2006, 2007a,b; Erridge et al., 2010;
Bereswill et al., 2011; Fiebiger et al., 2016), we quantitatively
surveyed changes in distinct intestinal gut bacterial groups
and species applying culture-independent 16S rRNA based
methods (Figures 4A–I). Within 10 days p.i., enterobacteria
and enterococci had increased in luminal samples taken from
the inflamed ileum (p < 0.001; Figures 4B,C), but declined
thereafter (p < 0.05–0.001; Figures 4B,C), whereas obligate
anaerobic Gram-negative species such as Bacteroides / Prevotella
species were slightly higher at either time point p.i. as compared
to naive mice (p < 0.05; Figure 4F). Conversely, lactobacilli
were lower in ileal samples derived from T. gondii infected
mice (p < 0.01–0.001; Figure 4D), which also held true
for bifidobacteria at days 36 and 57 p.i. (p < 0.05–0.01;
Figure 4E). Converse to enterobacteria and enterococci, the
obligate anaerobic Clostridium coccoides and Mouse Intestinal
Bacteroides decreased to lowest levels until day 10 p.i. (p <
0.05–0.005; Figures 4G–I), but increased later-on (p < 0.05–
0.001; Figures 4G,I). For Clostridium leptum, a trend toward
lower gene numbers at day 10 p.i. as compared to naïve
conditions could be observed (n.s. due to high standard
deviations; Figure 4H), whereas bacterial loads were higher at
days 36 and 37 vs. day 10 p.i. (p < 0.001 and p < 0.01,
respectively; Figure 4H).
Of note, increased T. gondii DNA could be detected in small
intestinal ex vivo biopsies at day 10 p.i., but not later-on (p <
0.001; Figure 4J).
Hence, T. gondii induced immunopathological sequelae
observed in the ileum were accompanied by pronounced
shifts in the luminal gut microbiota composition in the distal
small intestines.
Extra-Intestinal Inflammatory Changes
Upon Peroral Low-Dose T. gondii Infection
We next surveyed potential T. gondii induced inflammatory
changes in extra-intestinal compartments over time. T. gondii
infected mice displayed elevated numbers of caspase3+ cells in
their livers exclusively at day 10 p.i. (p < 0.001; Figure 5A and
Figure S4A). In addition, hepatic F4/80+ cells had increased
as early as day 10 p.i. (p < 0.001), but declined to naive
numbers until day 57 p.i. (p < 0.001; Figure 5B and Figure S3B).
At either time point p.i., mice exhibited increased numbers
of both, T and B lymphocytes in their livers (p < 0.001;
Figures 5C,D and Figures S3C,D). Furthermore, T. gondii
FIGURE 4 | Ileal microbiota composition and parasitic loads over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) The total
eubacterial loads as well as the main gut bacterial groups (B–I, as indicated) and (J) T. gondii DNA were quantitated in ileal samples by culture-independent molecular
methods and expressed as gene numbers per ng DNA. Medians (black bars), levels of significance (p-values) as determined by one-way ANOVA test followed by
Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.
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FIGURE 5 | Microscopic inflammatory sequelae in the liver over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36 and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six
representative high power fields (HPF, 400x magnification) per animal the average numbers of (A) apoptotic (casapse3+, Casp3+) and (B) proliferating (Ki67+) cells
as well as of (C) T lymphocytes (CD3+) and (D) B lymphocytes were assessed in immunohistochemically stained hepatic paraffin sections. Medians (black bars),
levels of significance (p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in
parentheses) are indicated. Data were pooled from four independent experiments.
induced hepatic inflammatory cell responses were accompanied
by enhanced secretion of pro-inflammatory mediators measured
at day 10 p.i. (p < 0.001 vs. naive; Figures 6A–C). At
day 36 p.i., hepatic anti-inflammatory IL-10 concentrations
were lower as compared to those obtained at day 10 p.i.
(p < 0.01; Figure 6D).
Enhanced inflammatory responses upon low-dose T. gondii
infection could also be observed in the kidneys. In fact, at day 10
following T. gondii infection mice exhibited multifold increased
numbers of apoptotic cells in their kidneys, but not later-on
(Figure 7A and Figure S4A), whereas renal T cell numbers were
elevated at either time point p.i. (p < 0.05–0.001), but with
lower counts at day 57 vs. day 10 p.i. (p < 0.001; Figure 7B and
Figure S4B). Pathogen induced increases in renal B cell numbers
could be observed rather late in the course of infection (i.e., days
36 and 57 p.i.; p < 0.001; Figure 7C and Figure S4C). When
assessing pro-inflammatory mediator secretion in renal ex vivo
biopsies, nitric oxide, TNF and IFN-γ increased as early as day 10
p.i. (p < 0.001; Figures 8A–C). Conversely, IL-10 concentrations
were lower at days 10 and 36 p.i. when compared to naive mice
(p < 0.001; Figure 8D).
We further expanded our inflammatory survey to the
lungs. Apoptotic pulmonary cells dramatically increased until
day 10 p.i. (p < 0.001), but decreased back to naïve levels
later-on (p < 0.001; Figure 9A and Figure S5A). Low-dose
T. gondii infected mice further exhibited increased numbers
of F4/80+ cells in the lungs (p < 0.001) with maximum
counts at day 36 p.i. (Figure 9B and Figure S5B). In addition,
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 April 2019 | Volume 9 | Article 98
Heimesaat et al. Immunopathology in Murine Low-Dose Toxoplasma gondii-Infection
FIGURE 6 | Hepatic inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii on
day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) Nitric oxide, (B) TNF,
(C) IFN-γ and (D) IL-10 concentrations were measured in ex vivo biopsies taken from the liver at respective time points. Medians (black bars), levels of significance
(p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are
indicated. Data were pooled from four independent experiments.
pulmonary T lymphocytes were elevated at either time
point following T. gondii infection (p < 0.001; Figure 9C
and Figure S5C), whereas T. gondii induced increases in B
lymphocytes could be assessed in the later stages of the
infection (i.e., days 36 and 57 p.i.; p < 0.001) with highest
counts at the end of the survey; (p < 0.001; Figure 9D
and Figure S5D).
Interestingly, increased secretion of pro-inflammatory
cytokines such as TNF and IFN-γ (p < 0.001) as well as of
anti-inflammatory IL-10 concentrations (p < 0.05) could be
exclusively determined in lungs taken at the earliest time point
p.i. (Figure 10).
Remarkably, overt T. gondii induced inflammatory
changes could also be assessed in the heart as indicated
by increased numbers of apoptotic cells at days as well as
of T lymphocytes in the cardiac muscle of infected mice
(p < 0.01–0.001; Figures S6A,B, S7A,B), whereas highest
apoptotic cell numbers could be counted at the end of the
survey (p < 0.05 vs. d10 p.i.; Figures S6A, S7A). Furthermore,
cardiac B cell numbers were higher on days 36 and 57
p.i. as compared to earlier time points (p < 0.05–0.01;
Figures S6C, S7C).
Hence, pronounced inflammatory responses following
peroral low-dose T. gondii infection were not restricted
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FIGURE 7 | Microscopic inflammatory sequelae in the kidneys over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six
representative high power fields (HPF, 400x magnification) per animal the average numbers of (A) apoptotic (casapse3+, Casp3+) cells, of (B) T lymphocytes (CD3+)
and (C) B lymphocytes were assessed in immunohistochemically stained renal paraffin sections. Medians (black bars), levels of significance (p-values) as determined
by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled
from four independent experiments.
to the intestinal tract, but could also be observed in
extra-intestinal compartments.
Systemic Inflammatory Responses Upon
Peroral Low-Dose T. gondii Infection
We next assessed T. gondii induced immunopathological
responses in systemic compartments. Whereas, increased pro-
inflammatory cytokines such as IFN-γ and IL-12p70 could be
measured in splenic ex vivo biopsies at day 10 p.i. only (p< 0.001;
Figures 11A,B), anti-inflammatory IL-10 levels were deprived
in the spleen at either time point p.i. (p < 0.001; Figure 11C).
Strikingly, elevated TNF, IFN-γ, MCP-1 and IL-6 concentrations
were obtained in serum samples taken from T. gondii infected
mice at day 10 p.i. (p< 0.001), but declined back to baseline levels
later-on (p < 0.001; Figures 12A–D). In case of IL-10, slightly
increased serum concentrations could be exclusively observed at
day 36 p.i. (p < 0.05; Figure 12E).
Hence, inflammatory responses following peroral low-dose T.
gondii infection could be assessed even in systemic compartments
that were most pronounced within the first 10 days p.i.
DISCUSSION
The peroral high-dose T. gondii infection mouse model
has been proven to be well-suited for investigating the
underlying molecular mechanism of pathogen-host interactions
and subsequently induced acute small intestinal inflammation
(McLeod et al., 1989a,b; Liesenfeld et al., 1996, 1999; Liesenfeld,
2002; Vossenkamper et al., 2004; Heimesaat et al., 2006; Munoz
et al., 2009, 2011, 2015). In this context one needs to take into
consideration, however, that the severity of T. gondii induced
ileitis does not meet a linear causal relationship to the amount
of parasite cysts the mice had been challenged with. In fact, it
is rather a critical threshold of cyst number that needs to be
reached to induce the full-blown inflammatory scenario, further
depending on the parasitic strain and the genetic background
and sex of the murine host (Liesenfeld et al., 1999; Munoz
et al., 2011; Heimesaat et al., 2018a). Given the lethal outcome
within 7–10 days, information regarding long-term sequelae
of T. gondii ME49 strain induced intestinal inflammation are
scarce, however.
We have established a far less acute T. gondii induced ileitis
model by decreasing the numbers of the perorally applied
parasitic infection dose from >50 cysts to only one cyst per
recipient mouse (Dunay et al., 2008; Heimesaat et al., 2018a). One
can imagine that an accidental increase in the parasitic inoculum
may yield an unwantedly more severe ileitis with fatal outcome
within<2 weeks. Besides the critically low infection dose, distinct
host characteristics such as age and sex of the infectedmice might
impact the severity of induced immunopathology (Liesenfeld
et al., 1999; Dunay et al., 2008; Munoz et al., 2011; Heimesaat
et al., 2018a). Hence, the reproducibility and reliability of the
peoral low-dose T. gondii infection model critically depends
on highly standardized conditions and the experiences of the
handling researchers (Heimesaat et al., 2018a). However, with
the subacute ileitis model at hand, we are now able to survey the
interactions within the triangle relationship (“ménage-à-trois”) of
the parasitic pathogen, the host immunity and the commensal gut
microbiota during intestinal inflammation for 2 months (like in
the present study) or even longer. In our very recent low-dose T.
gondii infection studies mice were sacrificed at day 9 p.i. (Escher
et al., 2018; Heimesaat et al., 2018a).
In our actual immunopathological survey for more than 8
weeks, perorally low-dose T. gondii infected mice developed
subacute ileitis within 10 days that was characterized by
a non-lethal outcome, rather mild symptoms and mild-to-
moderate histopathological changes of the ileal mucosa, but no
intestinal necrosis at all. Furthermore, ileal epithelial apoptosis
was accompanied by a concomitant increased abundance of
proliferating/regenerating epithelial cells in the terminal ileum
counteracting the inflammatory damage. Remarkably, T. gondii
induced inflammatory changes did not exclusively affect the
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 April 2019 | Volume 9 | Article 98
Heimesaat et al. Immunopathology in Murine Low-Dose Toxoplasma gondii-Infection
FIGURE 8 | Renal inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii on
day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) Nitric oxide, (B) TNF,
(C) IFN-γ, and (D) IL-10 concentrations were measured in ex vivo biopsies taken from the kidneys at respective time points. Medians (black bars), levels of
significance (p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in
parentheses) are indicated. Data were pooled from four independent experiments.
terminal ileumwhich is considered the predilection site following
peroral high-dose T. gondii infection (Liesenfeld et al., 1996;
Munoz et al., 2011), but also the large intestinal tract given
that numbers of apoptotic epithelial cells as well as of T and
B lymphocytes in the mucosa and lamina propria of both, the
ileum and the colon were highest at day 10 post-infection, but
declined thereafter. These inflammatory cellular responses were
accompanied by enhanced pro-inflammatory mediator secretion
in ileum, colon and mesenteric lymph nodes that was also most
pronounced during the early phase of infection. In support,
in our previous acute ileitis studies in (with respect to their
gut microbiota) “humanized” mice we could demonstrate the
colonic co-affection upon peroral high-dose T. gondii infection
(von Klitzing et al., 2017a,b). Furthermore, Suzuki and colleagues
reported inflammatory changes within the large intestines
following peroral infection of IL-10−/− mice with 20 cysts of the
ME49 strain (Suzuki et al., 2000).
Remarkably, both peroral high-dose and low-dose T. gondii
infection resulted in pro-inflammatory sequelae that were not
restricted to the intestinal tract, but could also be observed in
extra-intestinal and even systemic compartments as shown in our
previous reports (von Klitzing et al., 2017a,b; Heimesaat et al.,
2018a,b) and actual study. Overall, T. gondii induced and T cell
driven pro-inflammatory immune responses were observed in
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 April 2019 | Volume 9 | Article 98
Heimesaat et al. Immunopathology in Murine Low-Dose Toxoplasma gondii-Infection
FIGURE 9 | Microscopic inflammatory sequelae in the lungs over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T.
gondii on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six
representative high power fields (HPF, 400x magnification) per animal the average numbers of (A) apoptotic (casapse3+, Casp3+) cells, of (B) macrophages and
monocytes (F4/80+), of (C) T lymphocytes (CD3+) and (D) B lymphocytes were assessed in immunohistochemically stained pulmonary paraffin sections. Medians
(black bars), levels of significance (p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of
analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.
extra-intestinal organs such as liver, kidneys, lungs, and heart
during the entire observation period, but were overall most
pronounced during the early phase (i.e., around day 10 p.i.).
Depending on respective parasitic infection (i.e., amount and
strain of cysts, application via the peroral vs. intraperitoneal
route) of mice with a defined genetic background, sampling
and detection techniques varying information regarding extra-
intestinal parasitic infection are available in the literature.
For instance, in one study exclusively assessing the parasitic
dissemination following peroral infection with 20 cysts of the
avirulent T. gondii C strain, parasitic loads had rapidly increased
in the lungs until days 7 to 10 and resolved until day 50 p.i.
(Derouin and Garin, 1991). Compared to pulmonary parasitic
detection, parasitemia was rather delayed during the acute
phase of infection (i.e., first 7 days p.i.), whereas low-level
parasitemia was shown to occur transiently later-on (Derouin
and Garin, 1991). In another infection study, T. gondii could
be detected in liver and lungs of mice as early as 7-10 days
following peroral challenge with 20 cysts of the avirulent C strain
(Sumyuen et al., 1995). Dubey reported parasitemia within 24 h
post peroral infection and parasitic invasion of extra-intestinal
organs including liver, lungs, kidneys, skeletal and heart muscle
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FIGURE 10 | Pulmonal inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) TNF, (B) IFN-γ,
and (C) IL-10 concentrations were measured in ex vivo biopsies taken from the lungs at respective time points. Medians (black bars), levels of significance (p-values)
as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated.
Data were pooled from four independent experiments.
FIGURE 11 | Splenic inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) IFN-γ, (B)
IL-12p70, and (C) IL-10 concentrations were measured in ex vivo biopsies taken from the spleen at respective time points. Medians (black bars), levels of significance
(p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are
indicated. Data were pooled from four independent experiments.
between days 11 and 15 p.i. (Dubey, 1997). In these studies,
however, no further information regarding immunopathological
sequelae within infected compartments are available. Following
challenge of C57BL/6 mice with 10 cysts of the ME49 strain
via the intraperitoneal route, Liesenfeld and colleagues reported
rather mild infiltration of lungs with inflammatory mononuclear
cells within 7 days p.i., whereas no inflammatory foci could
be assessed in other organs such as the heart or the large
intestines (Liesenfeld et al., 1996).
In our present low-dose T. gondii infection study, parasitic
DNA were detectable only in ileal ex vivo biopsies taken at day
10 p.i., but were below the detection limit in any other intestinal
or extra-intestinal ex vivo biopsies taken during the observation
period further underlining that the observed inflammatory
changes are rather due to the immunological responses of the
initial T. gondii challenge with one single cyst only. One needs
to take into consideration that the (parasitic) pathogen does
not necessarily need to be permanently in the infected body
compartment in order to induce inflammatory sequelae. It is
rather the initial hit set by the pathogen to the host subsequently
tipping the balance toward immunopathology (Alutis et al., 2015;
Heimesaat et al., 2016a,b,c; Grunau et al., 2017).
It is well known that the fine-tuned interactions between
the complex intestinal bacterial ecosystem and the host
are critical for immune homeostasis, cell physiology and
resistance to morbidities (Ekmekciu et al., 2017a). Hence,
disturbances in the orchestrated commensal gut microbiota
composition are associated with the development and outcome
of immunopathological diseases including gastrointestinal
inflammation (Heimesaat et al., 2006; Erridge et al., 2010;
Bereswill et al., 2011; Fiebiger et al., 2016; Ekmekciu et al., 2017a).
Our culture-independent survey of the gut bacterial changes
during low-dose T. gondii infection revealed that until day 10
p.i. (when the severity of induced ileitis was maximum) Gram-
negative bacterial commensals such as enterobacteria including
E. coli had increased in the inflamed ileal lumen, whereas
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FIGURE 12 | Systemic inflammatory mediator secretion over time following peroral low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). (A) TNF, (B) IFN-γ,
(C) MCP-1, (D) IL-6 and (E) IL-10 concentrations were measured in serum samples taken at respective time points. Medians (black bars), levels of significance
(p-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are
indicated. Data were pooled from four independent experiments.
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conversely, Gram-positive lactobacilli and clostridia as well as
Mouse Intestinal Bacteroides had decreased. These observations
are well in line with results derived from our lethal high-
dose T. gondii infection studies given that ileitis development
was accompanied by dramatic shifts in the ileal microbiota
compositions toward an overgrowth with enterobacterial
species, whereas bacterial commensal diversity was reduced and
particularly lactobacilli and clostridia were virtually undetectable
(Heimesaat et al., 2006, 2007a; Erridge et al., 2010). T. gondii
induced ileitis was further aggravated by Toll-like receptor
(TLR)−4 dependent signaling of lipopolysaccharide derived
from the cell walls of the overgrowing Gram-negative species
(Heimesaat et al., 2007a; Erridge et al., 2010). During the chronic
phase of low-dose T. gondii infection (i.e., at days 36 and 57 p.i.),
mice harbored fewer bifidobacteria but also lactobacilli in the
small intestines as compared to uninfected controls. Particularly
bifidobacteria and lactobacilli are considered “health-beneficial”
commensals with immuno-modulatory properties and sharing
important functions during immune homeostasis (Bereswill
et al., 2017; Ekmekciu et al., 2017b,c; Heimesaat et al., 2017).
Dysbiosis with deprived intestinal bifidobacterial loads has
been shown to be associated with celiac disease, irritable
bowel syndrome, inflammatory bowel disease (IBD) and atopic
diseases, for instance (Tojo et al., 2014). Furthermore, acute
ileitis was more pronounced in high-dose T. gondii infected
conventional mice that were gene deficient for either TLR-9 or
nucleotide-binding oligomerization domain (NOD) 2 and were
both lacking intestinal bifidobacterial commensals (Bereswill
et al., 2014; Heimesaat et al., 2014).
The murine low-dose T. gondii infection model has
most commonly been used in order to investigate parasitic
inflammation of the central nervous system given that upon
intraperitoneal challenge with <10 T. gondii cysts of the ME49
strain susceptible mice develop chronic cerebral inflammation
(Dunay et al., 2010; Biswas et al., 2015; Mohle et al., 2016; Lang
et al., 2018; Dusedau et al., 2019). However, for investigating
subacute/chronic intestinal and extra-intestinal (besides
neurological) immunopathological changes the low-dose
infection model has only been applied in single studies so far
(Dunay et al., 2008; Escher et al., 2018; Heimesaat et al., 2018a).
In conclusion, the here provided long-term kinetic survey
of immunopathological sequalae in intestinal, extra-intestinal
and systemic compartments following peroral low-dose T.
gondii infection provides valuable corner stones for a better
understanding of the complex interactions within the triangle
relationship of (parasitic) pathogens, the host immunity and
the commensal gut microbiota during subacute and chronic
intestinal inflammation. Furthermore, the low-dose T. gondii
infection model may be applied as valuable gut inflammation
model in future pre-clinical studies in order to test potential
treatment options for intestinal inflammatory conditions in
humans (Bereswill et al., 2019).
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Figure S1 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the ileum over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the ileum illustrate (A) histopathological changes (H&E staining) and (B) apoptotic
(caspase3+, Casp3+) cells, (C) proliferating (Ki67+) cells, (D) T lymphocytes
(CD3+), and (E) B lymphocytes (B220+) in immunohistochemically stained
paraffin sections at respective time points (100 x magnification, scale bar 100µm).
Figure S2 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the colon over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the colon illustrate (A) histopathological changes (H&E staining) and (B) apoptotic
(caspase3+, Casp3+) cells, (C) proliferating (Ki67+) cells, (D) T lymphocytes
(CD3+), and (E) B lymphocytes (B220+) in immunohistochemically stained
paraffin sections at respective time points (100 x magnification, scale bar 100µm).
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Figure S3 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the liver over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the liver illustrate (A) apoptotic (caspase3+, Casp3+) cells, (B)
macrophages/monocytes (F4/80+), (C) T lymphocytes (CD3+), and (D) B
lymphocytes (B220+) in immunohistochemically stained paraffin sections at
respective time points (100 x magnification, scale bar 100µm).
Figure S4 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the kidneys over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the kidneys illustrate (A) apoptotic (caspase3+, Casp3+) cells, (B) T lymphocytes
(CD3+), and (C) B lymphocytes (B220+) in immunohistochemically stained
paraffin sections at respective time points (100 x magnification, scale bar 100µm).
Figure S5 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the lungs over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the lungs illustrate (A) apoptotic (caspase3+, Casp3+) cells, (B)
macrophages/monocytes (F4/80+), (C) T lymphocytes (CD3+), and (D) B
lymphocytes (B220+) in immunohistochemically stained paraffin sections at
respective time points (100 x magnification, scale bar 100µm).
Figure S6 | Microscopic inflammatory sequelae in the heart muscle over time
following peroral low-dose T. gondii infection. Mice were perorally infected with
one cyst of T. gondii on day 0 and surveyed at days (d) 10, 36, and 57
post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls
(open circles). Out of six representative high power fields (HPF, 400x magnification)
per animal the average numbers of (A) apoptotic (casapse3+, Casp3+) cells, of
(B) T lymphocytes (CD3+) and (C) B lymphocytes were assessed in
immunohistochemically stained cardiac paraffin sections. Medians (black bars),
levels of significance (p-values) as determined by one-way ANOVA test followed
by Tukey post-correction for multiple comparisons and numbers of analyzed mice
(in parentheses) are indicated. Data were pooled from four
independent experiments.
Figure S7 | Representative photomicrographs illustrating inflammatory changes
and distinct immune cell populations in the heart over time following peroral
low-dose T. gondii infection. Mice were perorally infected with one cyst of T. gondii
on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N)
mice served as uninfected controls. Representative photomicrographs taken from
the heart illustrate (A) apoptotic (caspase3+, Casp3+) cells, (B) T lymphocytes
(CD3+), and (C) B lymphocytes (B220+) in immunohistochemically stained
paraffin sections at respective time points (100 x magnification, scale bar 100µm).
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